神经症患者MMPI测查结果临床分析

目的 探讨神经症患者的人格特征及MMPI的临床意义。方法 对心理咨询门诊神经症患者进行MMPI测查。结果 男女神经症患者的编码模式和剖析图相似。L、F、K、Pd、Sc量表与神经症诊断有密切关系。结论 神经症患者的基本人格特征为神经质人格，MMPI的测定为临床诊断，心理治疗、疗效评估提供了一定的参考价值。     

男性神经症患者MMPI五项研究量表结果分析

应用 MMPI 五项研究量表测查了四组男性神经症患者共134名,发现神经症患者的MAS、Dy 量表分数均显著高于正常男性,Do 量表分数明显低于正常男性。焦虑症者的 MAS 量表分数高于强迫症者。     

MMPI中美T分对神经症与正常人区分效度的对照研究

采用明尼苏达多相个性调查表 (MMPI) 中国版399题,对102例神经症与100例正常人进行测查,比较中国 T 分(不加 K)与美国 T 分(加 K)两种标准下 MMPI 的量表区分度。结果发现,采用中国 T 分后神经症组呈现较为典型的1.2.3.7型剖面图,从整体上更能反映神经症性个性偏移的特征。同时,2量表 (D) 特异性有所提高。但另一方面又发现,2、7量表以及含有这两个量表的两点或两点以上编码模式敏感性下降。上述结果在一效度检验组中得到证实。     

综合医院躯体形式障碍患者MMPI特征

目的 :了解躯体形式障碍患者MMPI及临床特征 ,并探讨其可能的机制。方法 :对他科转诊的综合医院躯体形式障碍患者 (符合CCMD - 3标准 ) 30例进行MMPI测试 ,与首诊于咨询门诊的 139例神经症性障碍患者作了比较 ,并分析两组诈病指数的差异。结果 :躯体形式障碍患者除Hs、F量表分高于首诊组 (P <0 .0 5 )外 ,其余均无差异 ;两组诈病指数差异无显著性 (P >0 .0 5 )。结论 :躯体形式障碍患者MMPI剖图特点与神经症性障碍患者无本质差异 ,且并未比神经症性障碍患者有更多的伪装倾向     

MMPI 临床诊断效度的研究

本研究使用判别分析的方法检验了 MMPI 在临床区分正常人、神经症与精神病的能力,并建立了可以应用于临床的 MMPI 判别函数模型。经交叉检度检验,MMPI 判别诊断与临床实际诊断的总符合率为 84.48%,Kappa 值为0.77,经显著性检验 P<0.001,说明 MMPI 在国内使用诊断效度是好的,可以做为精神科临床辅助诊断的工具。     

神经症、癔病、精神分裂症患者明尼苏达多相人格问卷测查分析

目的探讨神经症、癌症、精神分裂症患者明尼苏这多相人格问卷（MMPI）基本量表这一个性纬度方面的个性特征及其差异。方法应用MMPI测试软件对96例神经症患者,75例癔症患者及106例精神分裂症患者分别进行测试,记录3组患者基本量表得分,并进行统计学分析。结果3组患者基本量表得分,经单因素方差分析,除k和MF量表外,均有统计学意义（P〈0．05或P〈0．01）;神经症患者HS、D、Hy、Pd、Pt和Si量表分均显著高于癔症和精神分裂症患者（P〈0．05或P〈0．01）;癔症组F和Ma量表分显著高于精神分裂症和神经症组（P〈0．05）。L、Hs、D、Pd、Pa、Pt、Sc、Ma、Si各量表分均显著高于精神分裂症组（P〈0．05或P〈0．01）;精神分裂症患者L分最高,与癌症和神经症患者均有统计学意义（P〈0．01或P〈0．05）。结论神经症、癔症和精神分裂症患者均存在不同程度的个性偏离。且3组之间存在统计学显著差异。     

精神病人与神经症病人PHI测评结果对照分析

目的 精神病人与神经病人PHI测评结果分析。方法 采用宋维真教授修订的心理健康测查表（PHI），对139名精神病人和神经症病人进行测查。结果 精神病人PSD、HYP、UNR分数均明显高于神经症病人，高于常模两个标准差以上，神经症病人SOM、DEP、ANX分数均高于精神病人，这与宋维真教授修订的MMPI的测查结果基本一致。结论 PHI适合应用于精神病人和神经症病人的人格测查，其功能接近MMPI，操作性优于MMPI，韪数量小，操作时间短，可广泛应用于精神科临床工作中。     

神经症患者电针疗法前后MMPI测评

电针治疗神经症及其他精神疾病具有一定的疗效[1 3 ] ,但这些评定多为临床症状的评定 ,对于患者的认知和行为方式没有系统的评定。电针治疗对患者认知、情感的改变报道不多 ,现将我们的研究结果报告如下。本文对象为符合ＣＣＭＤ -2 -Ｒ诊断标准的 15例神经症患者 ,其中抑郁性神经症 7例 ,神经衰弱 5例 ,焦虑性神经症 1例 ,癔症 1例 ,疑病症 1例。采用中科院心理研究所宋维真等修订的ＭＭＰＩ问卷及指导手册 ,分别于治疗前后进行评定。表 1　治疗前后患者ＭＭＰＩＴ分的比较 (Ｘ±ＳＤ)治疗前(Ｎ =15)治疗后(Ｎ =15) ｔＬ 4 5 80± 3 16 52 …     

慢性疼痛患者与神经症患者MMPI模式特征的对照研究

目的：研究慢性疼痛患者的个性特征及其与神经症患者的异同。方法采用ＭＭＰＩ对５９例慢性疼痛患者进行测试，并将结果与社会症患者的ＭＭＰＩ模型式特征相比较。结果：慢性疼痛患者的ＭＭＰＩ表现为Ｈｓ、Ｄ、Ｈｙ、Ｐｔ等临床量表分升高，其模式特点与神经症患者的模式特征相一致，尤其与神经症中的疑病症和癔症有更多的相似之处。结论：慢性疼痛患者具有神经症患者类似的个性特征。     

神经症MMPI—2的测量分析

目的:分析神经症患者MMPI-2的测定结果:探讨编码模式特点,临床应用意义及与SDS,SAS的相关性,方法:对70例抑郁性神经症患者在住院两周内进行MMPI-2和SAS,SDS测试,对其中31例进行MMPI-2重复测试,结果:男女性患者的剖析图走势相似,男性高分点编码序列为72831,女性为28763,低自尊,工作,障碍,治疗反感等内容量表存在性别差异,焦虑,抑郁内容量表评分与SAS,SDS评分存在显著正相关,治疗前后的重复测试,说明MMPI-2的分值下降与临床症状的缓解相伴随.结论:不同性别神经症患者MMPI-2编码模式相似,内容量表能较好地反映患者的精神病症状,其分值下降与临床症状的缓解相伴随.     

Differential rates of psychopathology symptoms in periodic limb movement disorder, obstructive sleep apnea, psychophysiological insomnia, and insomnia with psychiatric disorder.

STUDY OBJECTIVE: To determine patterns and relative intensity of psychopathology, as measured by the Minnesota Multiphasic Personality Inventory (MMPI), in 108 patients with either psychophysiological insomnia (PI; n=20), insomnia with psychiatric disorder (IPD; n=30), periodic limb movement disorder (PLM; n=28), or obstructive sleep apnea (OSA; n=30). DESIGN: Cross-sectional. SETTING: University sleep disorders center. MEASUREMENTS AND RESULTS: Subjects completed the MMPI prior to overnight diagnostic polysomnographic assessment followed by Multiple Sleep Latency Test (MSLT). Seventy five percent of the entire sample had at least one MMPI elevation (T>70). Groups showed significant baseline differences in age, BMI, and MSLT latency (all ps<.05). Logistic regression indicated that even after statistically controlling for these three diagnostic covariates, MMPI elevation was more likely among PLM and IPD patients than OSA or PI patients (all ps<.05). Followup pairwise comparisons indicated that this same pattern of group differences occurred for the Depression, Psychasthenia, and Schizophrenia scales (all ps<.05). CONCLUSIONS: Irrespective of age, obesity, and daytime sleepiness, patients with untreated PLM or IPD are more likely to experience clinically significant psychological difficulties than those with either OSA or PI. These differences are most likely to be manifested in terms of depressive symptoms, anxiety symptoms (tension, worry, guilt), social alienation, and diminished mental concentration. Finally, PLM may be associated with greater MMPI elevations than previously suspected, and agree with earlier clinical reports of high rates of psychiatric treatment in PLM.     

MMPI basic scales vs. Two-point codes in the discrimination of psychopathological groups

Made comparisons between MMPI basic scales and two-point codes in the discrimination of brain-damaged, schizophrenic, neurotic, and alcoholic patients (N = 380). Although levels of group differentiation were relatively low for both scales and codes, the latter approach was seen to result in a considerable loss of information and a concomitant reduction in criterion- related validity.     

Minnesota Multiphasic Personality Inventory (MMPI) cluster groups among chronically ill patients: Relationship to illness adjustment and treatment outcome

Cluster analysis of the MMPI has been utilized widely in the chronic low back pain literature to try to identify reliable patient subtypes predictive of treatment outcome. We extended this methodology to patients with heterogeneous chronic medical conditions by replicating prototypic MMPI cluster group profiles and by relating cluster groups to clinical baseline and outcome data. Subjects were two independent samples (n=254 and n=263) of chronically ill patients admitted to an inpatient medicine/psychiatry unit. Using a four-cluster solution, similar cluster profile groups were replicated in both samples. Consistent differences emerged between cluster groups on functional impairment, psychiatric diagnoses, depression, and psychosomatic symptoms. Cluster group membership also predicted changes in functional impairment and depression six months after treatment. Results are discussed in terms of similarities between chronic low back pain and chronic illness and tailoring treatment to different patient types.This research was supported in part by a grant from the Henry J. Kaiser Family Foundation.     

Validity of a back pain classification scale for detecting psychological disturbance as measured by the MMPI

Constructed a Back Pain Classification Scale (BPCS) to detect serious psychological disturbance in low back pain patients, validated against the MMPI. One hundred and twenty patients with low back pain were classified as functional or organic on the basis of BPCS scores. The group identified as psychologically disturbed (functional) had significantly higher MMPI elevations on Scales F, HS, D, HY, PD, MF, PA, PT and SC. None of their scale scores was significantly lower than the group identified as organic. T-scores above 70 were present only on Scales 1 and 3, which suggests a high incidence of essentially neurotic disorders in patients classified as functional. The use of the BPCS as a viable alternative to the MMPI in the medical setting was discussed.     

The MMPI and chronic pain: The diagnosis of psychogenic pain

This study investigates the capacity of the MMPI to discriminate among groups of patients with different types of pain. When multivariate analysis of variance is used, the standard set of MMPI scales discriminates between acute pain and chronic pain but not between chronic pain of two different etiologies (surgicaliatrogenic vs. unknown). The three scales that discriminate acute from chronic pain patients are those in the neurotic triad, Hs, D, and Hy. The possibility that the unknown pain etiology group could be broken down into psychogenic pain and undetected somatogenic pathology subgroups was explored using cluster analysis. This procedure did not yield any group of patients who could be identified as having chronic pain of psychogenic origin. These results suggest that the MMPI is not a reliable tool for the differential diagnosis of chronic pain. It appears, however, that patterns of findings are partly contingent on population characteristics. Researchers should be cautious about generalizing to populations other than those from which samples are drawn.This research was supported in part by a grant from Roche Laboratories, Nutley, New Jersey, and the Anesthesiology Research Center, Grant No. GM1599-1-06, University of Washington, Seattle, Washington.     

Masculinity-femininity scale of the MMPI and intellectual functioning of female addicts

In a group of 85 female chronic alcoholics and other addicts, scores on the Raven's Matrices and on a multiple-choice version of WAIS Vocabulary were found unrelated to the 13 standard and 4 MMPI research scales and 3 MMPI indices (average profile elevation, average elevations of the neurotic and the psychotic triad) except for the relationship of the raw scores (r = -.32) and the IQ equivalents (r = -.30) on the Vocabulary test to Masculinity-Femininity scores and of IQ equivalents on the Matrices to Barron's Ego Strength scale (r = .32): Women with more extensive vocabulary scored lower on the Masculinity-Femininity scale, and women with better visuo-spatial reasoning skills obtained higher Ego Strength scores.     

A multimethod evaluation of the MMPI in a chronic pain patient sample

Previous reports on the use of the MMPI with chronic pain patients have produced a variety of results. No single configural feature or scale identifies the chronic pain patient, regardless of the origin or verifiability of the etiology of the pain. Elevations on the neurotic triad occur frequently, but do not have the specificity of more recently reported chronic-pain subtypes on the MMPI. The present nonexperimental study (N = 72) provides an example of a multi-method analysis of a carefully selected sample of chronic pain patients without physical findings. Blind clinical analysis, simple two-point code aggregation, and multivariate profile methods were used and produced similar subtypes of the sample and understanding of the data. The obtained sample subtypes were similar to those found in other studies and were hypothesized to be related to each other along an underlying continuum of what might be depression. Further research is needed to facilitate understanding of the causation of chronic pain of obscure origin.     

Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital

BACKGROUND: In Brazil, treatment of panic disorder is most frequently initiated with pharmacotherapy, but only half of the patients can be expected to be panic free after medication. Studies have suggested that individual or group cognitive-behavior therapy (CBT) is an effective treatment strategy for panic patients who have failed to respond to pharmacotherapy. METHODS: Thirty-two patients diagnosed with panic disorder with agoraphobia having residual symptoms despite being on an adequate dose of medication were treated with 12 weeks of group CBT. The outcome was evaluated for panic frequency and severity, generalized anxiety, and global severity. Comorbid conditions, a childhood history of anxiety, and defense mechanism styles were assessed as potential predictors of treatment response. RESULTS: Twenty-nine patients completed the 12-week protocol. Treatment was associated with significant reductions in symptom severity on all outcome measures (p < 0.001). Patients with depression had a poorer outcome of the treatment (p = 0.01) as did patients using more neurotic (p = 0.002) and immature defenses (p = 0.05). CONCLUSION: Consistent with previous reports, we found that CBT was effective for our sample of treatment-resistant patients. Among these patients, depression as well as neurotic defense style was associated with a poorer outcome. The use of CBT in Brazil for treatment-resistant and other panic patients is encouraged.